HK1078781A1 - Processes for preparing 1,3-dioxolane nucleosides - Google Patents

Processes for preparing 1,3-dioxolane nucleosides

Info

Publication number
HK1078781A1
HK1078781A1 HK05110765.7A HK05110765A HK1078781A1 HK 1078781 A1 HK1078781 A1 HK 1078781A1 HK 05110765 A HK05110765 A HK 05110765A HK 1078781 A1 HK1078781 A1 HK 1078781A1
Authority
HK
Hong Kong
Prior art keywords
preparing
processes
dioxolane nucleosides
nucleosides
dioxolane
Prior art date
Application number
HK05110765.7A
Other languages
English (en)
Inventor
Kyoichi A Watanabe
Jinfa Du
Original Assignee
Pharmasset Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmasset Inc filed Critical Pharmasset Inc
Publication of HK1078781A1 publication Critical patent/HK1078781A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/32Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/16Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/20Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
HK05110765.7A 2002-08-06 2005-11-25 Processes for preparing 1,3-dioxolane nucleosides HK1078781A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40165502P 2002-08-06 2002-08-06
PCT/US2003/024986 WO2004028445A2 (en) 2002-08-06 2003-08-06 Processes for preparing 1,3-dioxolane nucleosides

Publications (1)

Publication Number Publication Date
HK1078781A1 true HK1078781A1 (en) 2006-03-24

Family

ID=32043165

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05110765.7A HK1078781A1 (en) 2002-08-06 2005-11-25 Processes for preparing 1,3-dioxolane nucleosides

Country Status (14)

Country Link
US (1) US6855821B2 (es)
EP (1) EP1534255B1 (es)
JP (1) JP4560407B2 (es)
KR (1) KR101108115B1 (es)
AT (1) ATE496054T1 (es)
AU (1) AU2003294212B2 (es)
BR (1) BR0313302A (es)
CA (1) CA2494183C (es)
DE (1) DE60335805D1 (es)
ES (1) ES2360096T3 (es)
HK (1) HK1078781A1 (es)
IL (2) IL166682A0 (es)
MX (1) MXPA05001451A (es)
WO (1) WO2004028445A2 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100406017C (zh) * 2002-12-09 2008-07-30 佐治亚大学研究基金会 用于对抗hiv抗性株的二氧戊环基胸腺嘧啶及其组合物
ES2586668T3 (es) 2003-05-30 2016-10-18 Gilead Pharmasset Llc Análogos de nucleósidos fluorados modificados
US7785839B2 (en) 2004-02-03 2010-08-31 Emory University Methods to manufacture 1,3-dioxolane nucleosides
US7956087B2 (en) * 2005-04-21 2011-06-07 Kao Corporation Cosmetic composition for skin and wrinkle improver
AU2009223833A1 (en) * 2008-03-03 2009-09-17 Stiefel Laboratories, Inc. Processes for preparing enantiomerically pure diol and dioxolane compounds

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3028519A1 (de) * 1980-07-28 1982-02-25 Dynamit Nobel Ag, 5210 Troisdorf Substituierte 2,5,7-trioxan-bicyclo (2.2.2) octan-6-one und 3,6,8-trioxa-bicyclo (3.2.1) octan-4-one und verfahren zu deren herstellung
US5047407A (en) 1989-02-08 1991-09-10 Iaf Biochem International, Inc. 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
US5204466A (en) 1990-02-01 1993-04-20 Emory University Method and compositions for the synthesis of bch-189 and related compounds
US5276151A (en) 1990-02-01 1994-01-04 Emory University Method of synthesis of 1,3-dioxolane nucleosides
US5925643A (en) * 1990-12-05 1999-07-20 Emory University Enantiomerically pure β-D-dioxolane-nucleosides
IT1244501B (it) 1991-03-22 1994-07-15 Sigma Tau Ind Farmaceuti Derivati amminoacilici e oligopeptidici dell'allopurinolo dotati di attivita' immunostimolante e composizioni farmaceutiche che li contengono
ZA923640B (en) 1991-05-21 1993-02-24 Iaf Biochem Int Processes for the diastereoselective synthesis of nucleosides
GB9525606D0 (en) 1995-12-14 1996-02-14 Iaf Biochem Int Method and compositions for the synthesis of dioxolane nucleosides with › - configuration
US5792773A (en) * 1996-11-15 1998-08-11 Yale University L-β-dioxolane uridine analog administration for treating Epstein-Barr virus infection
IT1301977B1 (it) * 1998-07-31 2000-07-20 Sigma Tau Ind Farmaceuti Procedimento per la preparazione di r-(-)-carnitina
ES2232169T3 (es) 1998-08-12 2005-05-16 Gilead Sciences, Inc. Procedimiento de fabricacion de nucleosidos de 1,3-oxatiolano.
ATE254126T1 (de) 1998-12-23 2003-11-15 Shire Biochem Inc Antivirale nukleosidanaloga

Also Published As

Publication number Publication date
JP2006504703A (ja) 2006-02-09
JP4560407B2 (ja) 2010-10-13
EP1534255A4 (en) 2006-10-18
AU2003294212A1 (en) 2004-04-19
AU2003294212B2 (en) 2010-01-07
WO2004028445A2 (en) 2004-04-08
BR0313302A (pt) 2005-06-28
IL166682A (en) 2011-06-30
ES2360096T3 (es) 2011-05-31
EP1534255A2 (en) 2005-06-01
CA2494183C (en) 2012-01-03
WO2004028445A3 (en) 2004-06-10
ATE496054T1 (de) 2011-02-15
US6855821B2 (en) 2005-02-15
MXPA05001451A (es) 2005-09-30
KR20050052461A (ko) 2005-06-02
EP1534255B1 (en) 2011-01-19
CA2494183A1 (en) 2004-04-08
IL166682A0 (en) 2006-01-15
KR101108115B1 (ko) 2012-01-31
DE60335805D1 (de) 2011-03-03
US20040087806A1 (en) 2004-05-06

Similar Documents

Publication Publication Date Title
WO2002098865A3 (fr) Inhibiteurs des phosphodiesterases des nucleotides cycliques, preparation et utilisations de ces inhibiteurs
GEP20074099B (en) 3-β-D-RIBOFURANO-SYLTHIAZOLO[4,5-d]PYRIDIMINE NUCLEOSIDES AND USES THEREOF
HK1053122A1 (en) Pyrimidine compounds and their use in the preparation of a triazolo-pyrimidine carba nucleoside
WO2002102313A3 (en) Pyrimidine inhibitors of phosphodiesterase (pde) 7
IL166710A0 (en) Process for the preparation of 4-ÄÄ4-ÄÄ-(2-cyanoethenyl)2,6-dimethylphenylÜaminoÜ-2-pyrimidinylÜaminoÜbenzonitrile
WO2003015798A1 (en) Novel virus proliferation inhibition/virucidal method and novel pyradine nucleotide/pyradine nucleoside analogue
IL163781A0 (en) Purine derivatives as kinase inhibitors
IL112539A (en) Chloropyrimidine intermediates for preparing-2-aminopurine nucleoside analogues and their preparation
NZ527470A (en) Acylated indanyl amines and their use as pharmaceuticals
MXPA03001431A (es) Polimeros de un analogo de epotilona.
DE69025529T2 (de) Weitere antivirale Pyrimidin-Nukleosiden
IL172015A0 (en) Pyrimidine compounds having phosphonate groups as antiviral nucleotide analogs
PT1280813E (pt) Analogos de nucleosidos de pirimidina antivirais
HK1078781A1 (en) Processes for preparing 1,3-dioxolane nucleosides
MXPA03008811A (es) Procedimiento para la preparacion de 4,6-diaminopirimido (5,4-d) pirimidinas.
AU2003248647A1 (en) Stereoselective synthesis of 1,2-disubstituted cycloalkyls
AU2003272886A1 (en) (1,2,4)-TRIAZOLO(1,5-c)PYRIMIDINE DERIVATIVE
WO2003002580A8 (en) 6-`2-(phosphonomethoxy)alkoxy pyrimidine derivatives having antiviral activity
GB0229081D0 (en) Multifunctional cationic photoinitiators, their preparation and use
HK1034512A1 (en) Process for the production of purine derivatives and intermediates therefor
AU8204001A (en) Process for the preparation of baccatin iii derivatives
EP1613606A4 (en) PROCESS FOR PREPARING 2,3,5,6-SUBSTITUTED 3H-PYRIMIDIN-4-ONES
AU2003276009A1 (en) Regulation of human 3', 5' cyclic nucleotide phosphodiesterase pde1c
WO2004039808A3 (en) Process for the preparation of ganciclovir
WO2004096828A3 (fr) Nouveau procede et intermediaires de preparation de composes 19-nor-steroïdes

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20150806